Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 1:354:i4351.
doi: 10.1136/bmj.i4351.

Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study

Miranda M Fidler  1 , Raoul C Reulen  1 , David L Winter  1 , Julie Kelly  1 , Helen C Jenkinson  2 , Rod Skinner  3 , Clare Frobisher  1 , Michael M Hawkins  4 ; British Childhood Cancer Survivor Study Steering Group
Affiliations

Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study

Miranda M Fidler et al. BMJ. .

Abstract

Objective: To determine whether modern treatments for cancer are associated with a net increased or decreased risk of death from neoplastic and non-neoplastic causes among survivors of childhood cancer.

Design: Population based cohort study.

Setting: British Childhood Cancer Survivor Study.

Participants: Nationwide population based cohort of 34 489 five year survivors of childhood cancer with a diagnosis from 1940 to 2006 and followed up until 28 February 2014.

Main outcome measures: Cause specific standardised mortality ratios and absolute excess risks are reported. Multivariable Poisson regression models were utilised to evaluate the simultaneous effect of risk factors. Likelihood ratio tests were used to test for heterogeneity or trend.

Results: Overall, 4475 deaths were observed, which was 9.1 (95% confidence interval 8.9 to 9.4) times that expected in the general population, corresponding to 64.2 (95% confidence interval 62.1 to 66.3) excess deaths per 10 000 person years. The number of excess deaths from all causes declined among those treated more recently; those treated during 1990-2006 experienced 30% of the excess number of deaths experienced by those treated before 1970. The corresponding percentages for the decline in excess deaths from recurrence or progression and non-neoplastic causes were 30% and 60%, respectively. Among survivors aged 50-59 years, 41% and 22% of excess deaths were attributable to subsequent primary neoplasms and circulatory conditions, respectively, whereas the corresponding percentages among those aged 60 years or more were 31% and 37%.

Conclusions: The net effects of changes in cancer treatments, and surveillance and management for late effects, over the period 1940 to 2006 was to reduce the excess number of deaths from both recurrence or progression and non-neoplastic causes among those treated more recently. Among survivors aged 60 years or more, the excess number of deaths from circulatory causes exceeds the excess number of deaths from subsequent primary neoplasms. The important message for the evidence based surveillance aimed at preventing excess mortality and morbidity in survivors aged 60 years or more is that circulatory disease overtakes subsequent primary neoplasms as the leading cause of excess mortality.

PubMed Disclaimer

Conflict of interest statement

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: MMF, DLW, and JK were supported by grant number C386/A10422 from Cancer Research UK and/or PanCareSurFup from the European 7th Framework Programme; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

References

    1. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2008;100:1368-79. 10.1093/jnci/djn310. pmid:18812549. - DOI - PMC - PubMed
    1. Reulen RC, Winter DL, Frobisher C, et al. British Childhood Cancer Survivor Study Steering Group. Long-term cause-specific mortality among survivors of childhood cancer. JAMA 2010;304:172-9. 10.1001/jama.2010.923. pmid:20628130. - DOI - PubMed
    1. Garwicz S, Anderson H, Olsen JH, et al. Association of the Nordic Cancer Registries Nordic Society for Pediatric Hematology Oncology. Late and very late mortality in 5-year survivors of childhood cancer: changing pattern over four decades--experience from the Nordic countries. Int J Cancer 2012;131:1659-66. 10.1002/ijc.27393. pmid:22170520. - DOI - PubMed
    1. Brewster DH, Clark D, Hopkins L, et al. Subsequent mortality experience in five-year survivors of childhood, adolescent and young adult cancer in Scotland: a population based, retrospective cohort study. Eur J Cancer 2013;49:3274-83. 10.1016/j.ejca.2013.05.004. pmid:23756361. - DOI - PubMed
    1. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al. Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 2004;42:563-73. 10.1002/pbc.20028. pmid:15127410. - DOI - PubMed